poisar

Stock

Scienture Holdings, Inc. SCNX

$0.37-2.48%

Overview

SCNX market data

Price History

SCNX price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.70
Diluted earnings per share over the trailing twelve months.
Beta
3.01
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
1,428.6%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.24 – $2.60
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $15.3 · P/B 0.30 · P/S 23.69.

Company News

9 captured
Scienture To Begin Shiptments Of REZENOPY Nasal Spray 10mg To U.S. Pharmaceutical Wholesalers Later This MonthBenzinga · Jul 9, 2026, 12:20 PM
Scienture Announces Progress Towards Commercialization Of Its Arbli Oral Suspension Including Expanded Payor Coverage, Broader Pharmacy Access And New Channel PartnershipsBenzinga · Jun 18, 2026, 12:15 PM
FDA Broadens Access to Over-The-Counter Naloxone Nasal Spray for Opioid OverdoseBenzinga · Jun 16, 2026, 12:55 PM
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial LaunchBenzinga · Jun 9, 2026, 11:50 AM
EXCLUSIVE: SCIENTURE Secures Formulary Coverage For REZENOPY; Commercial Launch Planned For Mid-JulyBenzinga · Jun 9, 2026, 11:50 AM
Scienture Holdings Holds Exclusive U.S. Distribution Rights For Kindeva Drug Subsidiary Summit BioSciences' Rezenopy Nasal Spray, Which Received A U.S. Patent Effective May 12Benzinga · Jun 2, 2026, 12:23 PM
Scienture Eric Sherb Resigns As CFO Effective May 26, 2026; Narasimhan Mani Appointed As Interim CFO Effective May 26, 2026Benzinga · May 29, 2026, 9:10 PM
8-K filing — Scienture Holdings, Inc. (SCNX)SEC EDGAR · May 29, 2026, 9:00 PM
Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoYBenzinga · May 15, 2026, 10:12 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock